Which hedge funds own PCRX? PACIRA BIOSCIENCES INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
5 of the hedge funds tracked by WhaleCreep disclosed a position in PCRX (PACIRA BIOSCIENCES INC) in their Q2 2026 13F filings, worth $106.8m in total. The largest holder by portfolio weight is Renaissance Technologies LLC at 0.1% of its book. 1 manager opened a new position this quarter: Marshall Wace.
5tracked managers holding
1opened this quarter
0exited this quarter
Which hedge funds hold PCRX? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Renaissance Technologies LLC | Q2 2026 | 0.1% | $44.0m | 1,733,801 | -5% | reduced |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $49.5m | 1,950,332 | -2% | reduced |
| Millennium Management | Q2 2026 | 0.0% | $6.0m | 235,163 | 312% | added |
| Marshall Wace | Q2 2026 | 0.0% | $3.3m | 129,348 | – | new |
| Citadel Advisors | Q2 2026 | 0.0% | $4.1m | 162,164 | -80% | reduced |
How has hedge fund ownership of PCRX changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 5 | $106.8m |
| Q1 2026 | 4 | $105.4m |
| Q4 2025 | 2 | $49.0m |
| Q3 2025 | 2 | $55.6m |
| Q2 2025 | 1 | $57.3m |
| Q1 2025 | 3 | $56.3m |
| Q4 2024 | 4 | $58.3m |
| Q3 2024 | 2 | $30.3m |
| Q2 2024 | 2 | $86.6m |
| Q1 2024 | 3 | $88.4m |
| Q4 2023 | 4 | $125.9m |
| Q3 2023 | 5 | $138.6m |
| Q2 2023 | 6 | $165.1m |
| Q1 2023 | 5 | $205.9m |
| Q4 2022 | 4 | $159.4m |
| Q3 2022 | 4 | $250.5m |
Counts every tracked manager that disclosed PCRX in that quarter's filing, including managers that have since stopped filing.